Cumulative Intracranial Tumor Volume as a Prognostic Factor in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery.

Volume: 128, Pages: 57 - 69
Published: Jan 1, 2021
Abstract
Approximately 25–35% of all cancer patients suffer from brain metastases (BM), and many of them—in particular, those with a limited number of intracranial tumors—are treated with stereotactic radiosurgery (SRS). Accurate prediction of survival remains a key clinical challenge in this population. Several prognostic scales have been developed to facilitate this prognostication, including the Recursive Partitioning Analysis (RPA) classification,...
Paper Details
Title
Cumulative Intracranial Tumor Volume as a Prognostic Factor in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery.
Published Date
Jan 1, 2021
Volume
128
Pages
57 - 69
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.